Resolvyx reports dry eye data

Resolvyx Pharmaceuticals Inc. (Bedford, Mass.) said that in the Phase I/II 08-004-03 trial in 232 patients with moderate dry eye, topical RX-10045 twice daily met the co-primary endpoint of significan...